Senior VP, Global Head Clinical Development
Alan Slade joined ITBMed in January 2019 and has over 15+ years of experience in global drug development across Phase I – III. Alan holds a Doctor of Pharmacy from Purdue University and completed a Post-Doc Fellowship in clinical pharmacology with Rutgers University. His development experience has primarily been on immunosuppression and immunomodulation in solid-organ transplantation as well as rheumatology, ophthalmology and nephrology.
Alan is the inventor on several patents and has authored over 30 publications and book chapters in the field of transplantation and nephrology. Prior to joining ITBMed, Alan was with Novartis Pharmaceuticals, most recently as Director, Clinical Development for Transplantation and Rheumatology responsible for Phase II-IV clinical development and submissions for both novel and marketed compounds in transplantation, autoimmunity and autoinflammatory indications.